http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100331174-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B02C9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B03C1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B02C11-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 |
| filingDate | 2000-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100331174-B1 |
| titleOfInvention | Pharmaceutical composition for hepatitis B comprising the extract of Eugenia caryophyllata as a pharmaceutically active ingredient |
| abstract | The present invention relates to a new medical use of the clove extract, and more particularly, to a hepatitis B therapeutic agent comprising the water extract of the clove, its dry powder or a water-soluble fraction obtained by dissolving it in water and centrifugation. Clove extract of the present invention shows an excellent effect in the field of treatment of HBV infection that does not yet have a stable and effective therapeutic agent, the toxicity is also significantly lower than the known compounds, the manufacturing process is also very simple and economical and effective hepatitis B virus infection It can be used as a therapeutic agent. |
| priorityDate | 2000-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.